Objetivo
The general objective of INNOCHEM is to develop innovative chemokine-based therapeutic strategies for autoimmunity and chronic inflammation. The project is based on the scientific excellence of the applicants, which have made major recognized contributions to the field since the very beginning of chemokine discovery, and on the construction of shared technological platforms.
This will include:
- proteomics and
- transcriptional profiling for the outline of the "chemokinome" in pathophysiological conditions and identification of new antagonists;
- molecular modelling of agonist/antagonist receptor or agonist/inhibitor interaction, for pharmacology and drug design; iv) gene modified mice for target validation in autoimmune disorders.
Genetic, structural, biological, and immunopathological studies will provide a framework for the development of innovative chemokine-based therapeutic strategies. The therapeutic approaches to be investigated are innovative and not limited to conventional antagonists. These will include decoy receptors, agonist binders, and non-competitive allosteric inhibitors. In addition to academic groups, therapy-oriented research will include 3 biotech SMEs, and 3 Pharma companies. The companies involved develop complementary non-overlapping approaches to target the chemokine system with recombinant and low molecular weight molecules.
INNOCHEM is expected to conduct a "proof of principle" clinical study in volunteers in the first 18 months. The ambition of this project is to re-establish European leadership in basic and applied chemokine research by integrating academic and industrial cutting edge groups to develop innovative therapeutic strategies against autoimmunity and chronic inflammatory disorders.
Ámbito científico
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteinsproteomics
- medical and health scienceshealth sciencesinflammatory diseases
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugs
- medical and health sciencesbasic medicinemedicinal chemistry
- medical and health sciencesbasic medicineimmunology
Convocatoria de propuestas
FP6-2004-LIFESCIHEALTH-5
Consulte otros proyectos de esta convocatoria
Régimen de financiación
IP - Integrated ProjectCoordinador
ROZZANO-MILANO
Italia
Ver en el mapa
Participantes (28)
BELLINZONA
Ver en el mapa
PARIS
Ver en el mapa
PARIS
Ver en el mapa
LODZ
Ver en el mapa
740238 BERLIN
Ver en el mapa
BERN
Ver en el mapa
MUNICH
Ver en el mapa
BRUSSELS
Ver en el mapa
LONDON
Ver en el mapa
FIRENZE
Ver en el mapa
COPENHAGEN
Ver en el mapa
LEUVEN
Ver en el mapa
LONDON
Ver en el mapa
MILANO
Ver en el mapa
L'AQUILA
Ver en el mapa
ALLSCHWIL
Ver en el mapa
VIENNA
Ver en el mapa
GENEVA
Ver en el mapa
SIENA
Ver en el mapa
L'AQUILA
Ver en el mapa
BELO HORIZONTE MG
Ver en el mapa
CARDIFF
Ver en el mapa
GLASGOW
Ver en el mapa
LONDON
Ver en el mapa
ROMA
Ver en el mapa
PLAN LES OUATES
Ver en el mapa
2213 REHOVOT
Ver en el mapa
MADRID
Ver en el mapa